Introduction {#s1}
============

Diabetic retinopathy is clinically defined as damage to the retinal vasculature. The early clinical changes, which include microaneurysms and small intraretinal hemorrhages, are followed by capillary loss and, eventually, neovascularization. Increased vascular endothelial growth factor (VEGF) is an important mediator of these vascular abnormalities and a major contributor to the pathology of diabetic retinopathy ([@B1]).

Tissue hypoxia is one of the possible causes of increased VEGF. Hypoxia is implicated in the pathogenesis of diabetic retinopathy ([@B2]), but its onset, severity, and role in VEGF upregulation are still unclear. Several studies have provided evidence of hypoxia in the diabetic retina. Direct intraretinal oxygen measurements in cats with long-term diabetes (6--8 years) showed that there was inner retinal hypoxia, but this study was limited to three animals at one time point ([@B3]). Also, oxygenation across the inner retina was heterogeneous, with some areas exhibiting hypoxia and other areas showing normal oxygenation. A second study suggested that the inner retina was hypoxic in rats at 5 weeks, but few details were available ([@B4]). Finally, diabetic mice showed, after 5 months, increased inner retinal staining with pimonidazole HCl, a histochemical marker for tissue hypoxia ([@B5]). Studies in humans also provide indirect evidence of retinal hypoxia. In diabetic patients with minimal retinopathy, breathing 100% oxygen significantly improved contrast sensitivity but had no effect on the contrast sensitivity of control subjects without diabetes ([@B6]). Some animal studies do not show hypoxia in diabetes, but these studies have been confined to vitreal PO~2~ measurements, which may be less sensitive than intraretinal measurements, and have generally been performed at relatively early time points ([@B7]--[@B9]). At a very late time point, in humans with proliferative retinopathy, the vitreous has been shown to have lower PO~2~ in diabetic rats than in controls ([@B10],[@B11])

The purpose of these experiments was to begin to determine the timing and extent of oxygenation changes in diabetic rats with intraretinal PO~2~ measurements and relate oxygenation to other pathological changes in these animals ([@B12]). While rats do not exhibit all of the vascular changes seen in human patients with diabetes, they do lose pericytes and endothelial cells ([@B13]), have increased VEGF ([@B12],[@B14]), and have substantial changes in retinal gene expression ([@B15],[@B16]). Here we have recorded intraretinal PO~2~ profiles in rats at 4 and 12 weeks after the induction of diabetes, with the hypothesis that diabetic rats would have lower PO~2~ in the inner retina than controls.

Research Design and Methods {#s2}
===========================

Induction of Diabetes {#s3}
---------------------

Animal experiments were performed in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by Northwestern University's Institutional Animal Care and Use Committee. Diabetes was induced in male Long-Evans rats between 50 and 57 days old with a single intraperitoneal injection of streptozotocin (Axxora LLC, San Diego, CA; 65 mg/kg rat, 6.5 mg/mL) in 0.05 mol/L sodium citrate buffer (pH 5). Rats with blood glucose levels greater than 300 mg/dL 2 days after induction were deemed diabetic. The rats were not treated with insulin. Age-matched controls received a single intraperitoneal injection of 0.05 mol/L sodium citrate buffer only (0.01 mL/g rat). Rats were weighed weekly ([Supplementary Fig. 1*A*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-0101/-/DC1)), and nonfasting blood glucose levels were measured from the tail vein using a Bayer CONTOUR Meter (Bayer HealthCare LLC, Mishawaka, IN). The meter read "HI" if blood glucose exceeded 600 mg/dL. Those readings were set at 600 mg/dL for the purpose of averaging ([Supplementary Fig. 1*B*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-0101/-/DC1)). Diabetic animals had blood glucose levels of 500 mg/dL or higher; controls had blood glucose levels of ∼120 mg/dL.

Experimental Design {#s4}
-------------------

The rats were divided into four groups: control and diabetic rats at 4 or 12 weeks after induction of diabetes. [Table 1](#T1){ref-type="table"} gives the number of animals in each group. PO~2~ data were collected during dark and light adaptation from all groups. The first priority was to make the measurements in dark adaptation (3--12 profiles/rat). PO~2~ profiles were collected from a smaller number of animals in light adaptation using illumination sufficient to saturate rod responses in the electroretinogram (∼80 lux). Data from 9 out of 10 control animals used in this study were also included in a study on normal rat retina ([@B17]).

###### 

Physiological parameters for each group as measured during intraretinal PO~2~ recordings

                                                      4 weeks       12 weeks                    
  --------------------------------------------------- ------------- ------------- ------------- -------------
  Number of animals[\*](#t1n1){ref-type="table-fn"}   4 (4)         5 (4)         6 (5)         5 (3)
  Arterial pH                                         7.32 ± 0.06   7.36 ± 0.03   7.37 ± 0.01   7.28 ± 0.03
  P~a~CO~2~ (mmHg)                                    44.6 ± 5.8    36.7 ± 2.3    39.1 ± 1.2    45.0 ± 5.4
  P~a~O~2~ (mmHg)                                     111.0 ± 6.2   110.2 ± 5.6   98.4 ± 4.5    96.1 ± 2.1
  Blood glucose (mg/dL)                               136 ± 6       354 ± 48      134 ± 14      359 ± 44
  Temperature (°C)                                    38.2 ± 0.6    37.3 ± 0.4    37.8 ± 0.1    38.5 ± 0.3
  Arterial pressure (mmHg)                            98 ± 6        99 ± 4        98 ± 4        90 ± 10
  Heart rate (bpm)                                    395 ± 4       365 ± 12      360 ± 11      348 ± 15

Values are given as *n* or mean ± SEM.

\*The number of rats from which light-adapted profiles were also collected appears in parentheses.

At ∼4 and 12 weeks after induction of diabetes, the rats were anesthetized with isoflurane for surgery and urethane during recordings, and PO~2~ depth profiles were recorded from the retina in vivo using double-barreled oxygen/voltage microelectrodes. Electrode preparation, animal preparation, and data collection and analysis were performed as previously described ([@B17]). After completing surgical preparations, the animal was paralyzed with pancuronium bromide and artificially ventilated. An arterial sample was taken shortly after paralysis for measurement of blood gases and glucose. Arterial values were adjusted if necessary by changes in the tidal volume provided by the respirator and the fraction of inspired oxygen. Thereafter, arterial samples were taken at ∼1 h intervals and adjusted if necessary. The blood gas and glucose values during the experiments are given in [Table 1](#T1){ref-type="table"}. Arterial blood pressure was measured via the arterial cannula, and if average pressure fell below ∼75 mmHg, the animal was given 6% hydroxyethyl starch (Hespan or Vetastarch) intravenously.

The eccentricity of penetrations could not be obtained, but the entry point of the electrode in the eye and the electrode angle were calculated to place the recordings in central retina, usually at one anterior-posterior "latitude," and over an ∼30° arc of nasal-temporal locations.

Statistics {#s5}
----------

All values in the text and figures are reported as mean ± SEM unless stated otherwise. Statistical significance was determined using a two-factorial ANOVA with two levels in each factor (2 × 2 ANOVA) and was defined as *P* \< 0.05. The factors for the ANOVA were time point (levels 4 and 12 weeks) and treatment (levels control and diabetic). ANOVA results are shown in [Supplementary Data](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-0101/-/DC1). Fisher protected least significant difference was used for post hoc analysis.

Results {#s6}
=======

Intraretinal PO~2~ Profiles {#s7}
---------------------------

The PO~2~ profiles were similar for control and diabetic rats at both time points, as shown by representative intraretinal PO~2~ profiles obtained during dark adaptation ([Fig. 1*A*](#F1){ref-type="fig"}, 4 weeks; [Fig. 1*B*](#F1){ref-type="fig"}, 12 weeks). The major features of intraretinal oxygen profiles in rats were described previously ([@B17],[@B18]). The outer retina, where the photoreceptors lie, is avascular and is located at 50--100% retinal depth. The minimum PO~2~ in the outer retina (P~min~) occurs at ∼75--85% retinal depth and corresponds to the photoreceptor inner segments. The inner retina is located at 0--50% retinal depth and is characterized by peaks corresponding to the location of the retinal vasculature.

![Example intraretinal PO~2~ profiles from control and diabetic rats at 4 weeks (*A*) and 12 weeks (*B*). The choroid is located beyond 100% retinal depth. The outer retina, where the photoreceptors lie, is avascular and is located at 50--100% retinal depth. The minimum PO~2~ in the outer retina (P~min~) occurs in the inner segment layer. The location of P~min~ in profiles can be affected by whether the electrode pulls on the retina and was not consistently different between diabetic rats and controls. The inner retina is located at 0--50% retinal depth and the vitreous is located at \<0% retinal depth.](4338fig1){#F1}

Characteristics of Outer Retinal Oxygenation in Diabetic Rat Retina {#s8}
-------------------------------------------------------------------

Choroidal PO~2~ (P~C~) was not different between control and diabetic rats at either time point ([Fig. 2*A*](#F2){ref-type="fig"}, [Supplementary Table 1](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-0101/-/DC1)). Photoreceptor oxygen consumption (Q~av~), obtained by fitting a model to the data ([@B17]), was also not significantly different between control and diabetic rats in dark or light adaptation ([Fig. 2*B*](#F2){ref-type="fig"}, [Supplementary Table 2](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-0101/-/DC1)). Light adaptation decreased Q~av~ to 51--65% of the dark-adapted value in each group, and diabetes had no effect on the light-induced change in Q~av~.

![Characteristics of outer retinal oxygenation were comparable for control and diabetic rats after 4 and 12 weeks of diabetes. *A*: The dark-adapted choroidal PO~2~ was not statistically different between the four groups. Black bars represent controls; white bars represent diabetic rats. *B*: Photoreceptor oxygen consumption (Q~av~) in both dark and light adaptation was comparable in the control and diabetic animals at 4 and 12 weeks after induction of diabetes. Light adaptation decreased Q~av~ compared with dark adaptation by a similar magnitude in all four groups. Black bars represent dark adaptation; white bars represent light adaptation. *C*: Minimum PO~2~ in inner segments of photoreceptors (P~min~) was comparable for control and diabetic rats at 4 and 12 weeks. Light adaptation increased P~min~ in all four groups. Black bars represent dark adaptation; white bars represent light adaptation. All error bars are SEM.](4338fig2){#F2}

Diabetes also had no effect on the minimum PO~2~ in the outer retina (P~min~) in dark adaptation ([Fig. 2*C*](#F2){ref-type="fig"}, [Supplementary Table 3](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-0101/-/DC1)). As expected, light adaptation increased P~min~ for all groups, and diabetes had no effect on light-adapted P~min~.

Average Inner Retinal PO~2~ {#s9}
---------------------------

The average inner retinal PO~2~ was computed for each profile over the inner 50% of the retina (P~IR~), and an average was then obtained across profiles for each animal. P~IR~ during dark adaptation appeared to be higher in the diabetic animals than in the controls, but the differences were not significant ([Fig. 3*A*](#F3){ref-type="fig"}, [Supplementary Table 4](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-0101/-/DC1)). However, in analyzing these data, we found that P~IR~ was significantly correlated with P~C~ in the same animal ([Fig. 3*B*](#F3){ref-type="fig"}). Since there was variability within and between groups, and because part of this correlation could be caused by errors applying the in vitro calibration to the in vivo data, P~IR~ was normalized to choroidal PO~2~ (P~IR~/P~C~) for each rat ([Fig. 3*C*](#F3){ref-type="fig"}). When analyzed this way, ANOVA showed a significant main effect for the treatment factor (diabetes; *P* = 0.005) and a significant interaction between time point and treatment (*P* = 0.004) ([Supplementary Table 5](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-0101/-/DC1)). Post hoc Fisher protected least significant difference showed that diabetic rats at 12 weeks had significantly higher P~IR~/P~C~ than the other three groups (*P* \< 0.005). All other comparisons were not significant.

![*A*: The average inner retinal PO~2~ (P~IR~) in control and diabetic rats was not significantly different after 4 and 12 weeks. *B*: Correlation between P~IR~ and choroidal PO~2~ (P~C~) for each rat. *C*: P~IR~ normalized to P~C~, which showed that P~IR~/P~C~ was comparable between control rats at 4 and 12 weeks and diabetic rats at 4 weeks. However, P~IR~/P~C~ was significantly higher in diabetic rats at 12 weeks than the three other groups (*P* \< 0.005). In *A* and *C*, black bars represent control; white bars represent diabetic; and error bars are SEM.](4338fig3){#F3}

Discussion {#s10}
==========

This study is only the third set of intraretinal PO~2~ measurements in any diabetic animal ([@B3],[@B4]). As expected, diabetes did not affect outer retinal oxygenation or oxygen consumption. The choroidal PO~2~, P~min~, and Q~av~ were comparable for the control and diabetic rats at both time points. Also, the response to light adaptation was similar for all four groups. All the physiological parameters indicated that the outer retina is unaffected in the early stages of diabetes.

Diabetes ultimately damages the vasculature of the inner retina. Therefore, the inner retinal oxygenation was hypothesized to decrease in diabetes, but the result was opposite to what was expected. Instead of hypoxia, diabetes caused P~IR~/P~C~ at 12 weeks to increase by ∼45% compared with age-matched controls. The confidence in this result is reinforced by a study using a very different technique, pimonidazole and immunofluorescence labeling, which showed that 12-week Long-Evans diabetic rats had significantly less staining in all layers of the retina than controls ([@B19]). This also strongly suggests a relative increase in inner retinal PO~2~ in diabetic rats at this time point and tends to rule out the possibility that the present result arose from recording selectively from different parts of the retina in control versus diabetic animals. The increase in P~IR~ could result from two possible causes. First, diabetes could cause retinal blood flow to increase, thereby bringing more oxygen to the inner retina and imbalancing the relation between supply and demand. No information is available about blood flow in pigmented rats. In albino (Sprague-Dawley and Wistar) rats, retinal blood flow decreased at 1, 2, 4, and 6 weeks after induction of diabetes compared with controls ([@B20],[@B21]). There is evidence of molecular differences among rat strains with respect to diabetes ([@B16]), so blood flow may also be affected differently in different strains. In the only previous intraretinal PO~2~ measurements in rats, the inner retina was reported to be hypoxic at 5 or 6 weeks ([@B4]). This was reported very briefly, but based on previous work from the same group, it is likely that these were Sprague-Dawley rats.

The second possible cause for increased P~IR~/P~C~ could be decreased oxygen consumption in the inner retina due to hyperglycemia-induced dysfunction or loss of neurons, assuming that blood flow does not concomitantly increase. We currently do not have methods to quantify inner retinal oxygen consumption in vivo. The oxygen profiles were collected in one dimension, and modeling oxygen consumption in the inner retina is a three-dimensional problem because of the presence of the retinal circulation. Nevertheless, other studies show neural cell loss in diabetes, which could lead to decreased oxygen consumption. Streptozotocin-induced diabetes significantly increased apoptosis and ganglion cell loss in Sprague-Dawley ([@B22]) and Brown Norway ([@B23]) rat retinas beginning as early as 1 month. Molecular data in Long-Evans rats also indicates neural dysfunction ([@B12]). In humans, retinal venous oxygen saturation is elevated even in background retinopathy ([@B24],[@B25]), which may correspond to the present results in rats and could also be caused by decreased metabolism.

The time points used in this study, 4 and 12 weeks after induction of diabetes, still represent very early stages in diabetes. We and others have shown that VEGF protein levels are higher in diabetic rats at 4 weeks ([@B12],[@B14],[@B16],[@B23]) and now can be certain that this is not caused by hypoxia. At 12 weeks of diabetes in rats, however, VEGF is not elevated relative to control ([@B12],[@B14]), which is consistent with the lack of hypoxia at this time. VEGF levels are elevated again in rats at 6 months ([@B26]). Retinal oxygenation may continue to change as the disease progresses, so retinal hypoxia should not yet be ruled out as a characteristic of long-standing diabetes in rats.

Supplementary Material
======================

###### Supplementary Data

This article contains Supplementary Data online at <http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-0101/-/DC1>.

**Funding.** This study was funded in part by National Eye Institute training grant T32 EY007128 and National Eye Institute grant R01 EY021165.

**Duality of Interest.** No potential conflicts of interest relevant to this article were reported.

**Author Contributions.** J.C.M.L. performed all experiments and was primarily responsible for data analysis and a draft of the manuscript. R.A.L. performed all experiments and edited and revised the manuscript. R.A.L. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

**Prior Presentation.** Parts of this study were presented in abstract form at the Annual Meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 2--6 May 2010.
